Want to join the conversation?
Therapeutic products maker $ANIK said the US FDA Office of Combination Products has allotted CINGAL, used to treat joint pain due to osteoarthritis, to the Center for Drug Evaluation and Research as the lead center for premarket review. Though $ANIK disagrees with FDA's decision, it intends to move swiftly to take CINGAL through regulatory review.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.